Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market to Witness Steady Growth (2019–2025)
Asia-Pacific digital PCR (dPCR) and real-time PCR (qPCR) market is driven by the rising prevalence of infectious and genetic diseases, increasing demand for rapid and accurate molecular diagnostics, and expanding applications in clinical research and forensic analysis. Growing investments in biotechnology, life sciences research, and precision medicine are further accelerating the adoption of PCR technologies across the region. In addition, advancements in quantitative PCR (qPCR) and digital PCR (dPCR) platforms are improving sensitivity, accuracy, and efficiency in nucleic acid detection, supporting broader usage in diagnostic and research laboratories.
Browse the full report description of “Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application), Forecast 2019-2025” at https://www.omrglobal.com/industry-reports/asia-pacific-digital-pcr-and-real-time-pcr-market
High-throughput molecular diagnostics PCR systems segment in Asia-Pacific is expected to account for a major market share in 2025–2026
High-throughput molecular diagnostics PCR systems in Asia-Pacific are expected to hold a major market share in 2025–2026, primarily due to the increasing demand for rapid, accurate, and scalable genetic testing technologies across clinical diagnostics and research laboratories. These systems are widely used for infectious disease detection, oncology research, genetic screening, and precision medicine applications, enabling faster turnaround times and improved diagnostic accuracy. Thermo Fisher Scientific expanded its Applied Biosystems PCR portfolio during 2025–2026 with new digital PCR automation and rapid qPCR workflow kits, strengthening adoption of high-throughput molecular diagnostics across Asia-Pacific laboratories. Rising investments in advanced healthcare infrastructure and growing adoption of molecular diagnostics are expected to significantly support segment growth.
Droplet digital PCR (ddPCR) oncology research platforms segment in Asia-Pacific is expected to account for a major market share in 2025
Droplet digital PCR (ddPCR) oncology research platforms in Asia-Pacific are expected to hold a major market share in 2025 owing to the increasing need for ultra-sensitive genetic analysis technologies capable of detecting rare mutations and low-abundance biomarkers in cancer research. These platforms provide high precision, absolute quantification, and enhanced reproducibility, making them highly suitable for oncology diagnostics and translational research applications. Bio-Rad Laboratories enhanced its Droplet Digital PCR (ddPCR) ecosystem during 2025 through expansion of QX-series systems and multiplex assay capabilities, improving rare mutation detection and oncology research applications across Asia-Pacific markets. Growing focus on precision oncology and expanding molecular research capabilities are expected to further accelerate the growth of the ddPCR oncology research platforms segment.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404